40
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice

, , , , , , & show all
Article: e00529-16 | Received 27 Sep 2016, Accepted 27 Oct 2016, Published online: 17 Mar 2023

REFERENCES

  • Palis J. 2014. Primitive and definitive erythropoiesis in mammals. Front Physiol 5:3. https://doi.org/10.3389/fphys.2014.00003.
  • Jelkmann W. 2013. Physiology and pharmacology of erythropoietin. Transfus Med Hemother 40:302–309. https://doi.org/10.1159/000356193.
  • Lee FS, Percy MJ. 2011. The HIF pathway and erythrocytosis. Annu Rev Pathol Mech Dis 6:165–192. https://doi.org/10.1146/annurev-pathol-011110-130321.
  • Prchal JT, Sokol L. 1996. Benign erythrocytosis and other familial and congenital polycythemias. Eur J Haematol 57:263–268.
  • Patnaik MM, Tefferi A. 2009. The complete evaluation of erythrocytosis: congenital and acquired. Leukemia 23:834–844. https://doi.org/10.1038/leu.2009.54.
  • Kim CH. 2010. Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med 1:13–19. https://doi.org/10.2147/JBM.S7224.
  • Wolber FM, Leonard E, Michael S, Orschell-Traycoff CM, Yoder MC, Srour EF. 2002. Roles of spleen and liver in development of the murine hematopoietic system. Exp Hematol 30:1010–1019. https://doi.org/10.1016/S0301-472X(02)00881-0.
  • Kaelin WG, Jr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30:393–402. https://doi.org/10.1016/j.molcel.2008.04.009.
  • Semenza GL. 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148:399–408. https://doi.org/10.1016/j.cell.2012.01.021.
  • Myllyharju J, Koivunen P. 2013. Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles. Biol Chem 394:435–448. https://doi.org/10.1515/hsz-2012-0328.
  • Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong G-H. 2006. Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 26:8336–8346. https://doi.org/10.1128/MCB.00425-06.
  • Minamishima YA, Moslehi J, Bardeesy Y, Cullen D, Bronson RT, Kaelin WG, Jr. 2008. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111:3236–3244. https://doi.org/10.1182/blood-2007-10-117812.
  • Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, Duan LJ, Takeda H, Lee FS, Fong GH. 2008. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111:3229–3235. https://doi.org/10.1182/blood-2007-09-114561.
  • Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A, Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz DM, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B. 2013. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Blood 121:1436–1445. https://doi.org/10.1182/blood-2012-08-449181.
  • Hyvärinen J, Hassinen IE, Sormunen R, Mäki JM, Kivirikko KI, Koivunen P, Myllyharju J. 2010. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J Biol Chem 285:13646–13657. https://doi.org/10.1074/jbc.M109.084855.
  • Kerkelä R, Karsikas S, Szabo Z, Serpi R, Magga J, Gao E, Alitalo K, Anisimov A, Sormunen R, Pietilä I, Vainio L, Koch WJ, Kivirikko KI, Myllyharju J, Koivunen P. 2013. Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection. Mol Cell Biol 33:3321–3329. https://doi.org/10.1128/MCB.00432-13.
  • Rahtu-Korpela L, Karsikas S, Hörkkö S, Blanco Sequeiros R, Lammentausta E, Mäkelä KA, Herzig KH, Walkinshaw G, Kivirikko KI, Myllyharju J, Serpi R, Koivunen P. 2014. HIF prolyl-4-hydroxylase-2 inhibition protects mice against obesity and metabolic syndrome. Diabetes 63:3324–3333. https://doi.org/10.2337/db14-0472.
  • Rahtu-Korpela L, Määttä J, Dimova EY, Hörkkö S, Gylling H, Walkinshaw G, Hakkola J, Kivirikko KI, Myllyharju J, Serpi R, Koivunen P. 2016. Hypoxia-inducible factor-prolyl 4-hydroxylase-2 inhibition protects against development of atherosclerosis. Arterioscler Thromb Vasc Biol 36:608–617. https://doi.org/10.1161/ATVBAHA.115.307136.
  • Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, Saikali KG, Franco M, Hemmerich S, Yu KH, Neff TB. 2016. Roxadustat (FG-4592): correction of anemia in incident dialysis patients. J Am Soc Nephrol 27:1225–1233. https://doi.org/10.1681/ASN.2015030241.
  • Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, Leong R, Hemmerich S, Yu KH, Neff TB. 2015. Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. Nephrol Dial Transplant 30:1665–1673. https://doi.org/10.1093/ndt/gfv302.
  • Laitala A, Aro E, Walkinshaw G, Mäki JM, Rossi M, Heikkilä M, Savolainen ER, Arend M, Kivirikko KI, Koivunen P, Myllyharju J. 2012. Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. Blood 120:3336–3344. https://doi.org/10.1182/blood-2012-07-441824.
  • Fortini ME, Artavanis-Tsakonas S. 1993. Notch: neurogenesis is only part of the picture. Cell 75:1245–1247. https://doi.org/10.1016/0092-8674(93)90611-S.
  • Artavanis-Tsakonas S, Matsuno K, Fortini ME. 1995. Notch signaling. Science 268:225–232. https://doi.org/10.1126/science.7716513.
  • Egan SE, St Pierre B, Leow CC. 1998. Notch receptors, partners and regulators: from conserved domains to powerful functions. Curr Top Microbiol Immunol 228:273–324.
  • Kopan R, Turner DL. 1996. The Notch pathway: democracy and aristocracy in the selection of cell fate. Curr Opin Neurobiol 6:594–601. https://doi.org/10.1016/S0959-4388(96)80090-0.
  • Honjo T. 1996. The shortest path from the surface to the nucleus: RBP-Jκ/Su(H) transcription factor. Genes Cells 1:1–9. https://doi.org/10.1046/j.1365-2443.1996.10010.x.
  • Lewis J. 1998. Notch signalling. A short cut to the nucleus. Nature 393:304–305. https://doi.org/10.1038/30597.
  • Borgrrefe T, Lauth M, Zwijsen A, Huylebroeck D, Oswald F, Giaimo BD. 2016. The notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. Biochim Biophys Acta 1863:303–313. https://doi.org/10.1016/j.bbamcr.2015.11.020.
  • Weinmaster G. 1997. The ins and outs of Notch signaling. Mol Cell Neurosci 9:91–102. https://doi.org/10.1006/mcne.1997.0612.
  • Bettenhausen B, Hrabe de Angelis M, Simon D, Guénet J-L. 1995. Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta. Development 121:2407–2418.
  • Dunwoodie SL, Henrique D, Harrison SM, Beddington SP. 1997. Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development 124:3065–3076.
  • Rao PK, Dorsch M, Chickering T, Zheng G, Jiang C, Goodearl A, Kadesch T, McCarthy S. 2000. Isolation and characterization of the Notch ligand Delta4. Exp Cell Res 260:379–386. https://doi.org/10.1006/excr.2000.5034.
  • Lindsell CE, Shawber CJ, Boulter J, Weinmaster G. 1995. Jagged: a mammalian ligand that activates Notch1. Cell 80:909–917. https://doi.org/10.1016/0092-8674(95)90294-5.
  • Shawber C, Boulter J, Lindsell CE, Weinmaster G. 1996. Jagged2: a serrate-like gene expressed during rat embryogenesis. Dev Biol 180:370–376. https://doi.org/10.1006/dbio.1996.0310.
  • Luo B, Aster JC, Hasserjian RP, Kuo F, Sklar J. 1997. Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor. Mol Cell Biol 17:6057–6067. https://doi.org/10.1128/MCB.17.10.6057.
  • Walker L, Carlson A, Tan-Pertel HT, Weinmaster G, Gasson J. 2001. The notch receptor and its ligands are selectively expressed during hematopoietic development in the mouse. Stem Cells 19:543–552. https://doi.org/10.1634/stemcells.19-6-543.
  • Jones P, May G, Healy L, Brown J, Hoyne G, Delassus S, Enver T. 1998. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 92:1505–1511.
  • Varnum-Finney B, Purton LE, Yu M, Brashem-Stein C, Flowers D, Staats S, Moore KA, Le Roux I, Mann R, Gray G, Artavanis-Tsakonas S, Bernstein ID. 1998. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 91:4084–4091.
  • Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G, Gasson JC. 1999. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells 17:162–171. https://doi.org/10.1002/stem.170162.
  • Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, Reya T. 2005. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6:314–322. https://doi.org/10.1038/ni1164.
  • Inra CN, Zhou BO, Acar M, Murphy MM, Richardson J, Zhao Z, Morrison SJ. 2015. A perisinusoidal niche for extramedullary haematopoiesis in the spleen. Nature 527:466–471. https://doi.org/10.1038/nature15530.
  • Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9:617–628. https://doi.org/10.1016/j.devcel.2005.09.010.
  • Chen H, Houshmand G, Mishra S, Fong G-H, Gittes GK. 2010. Impaired pancreatic development in Hif2-alpha deficient mice. Biochem Biophys Res Commun 399:440–445. https://doi.org/10.1016/j.bbrc.2010.07.111.
  • Hu YY, Fu LA, Li SZ, Chen Y, Li JC, Han J, Liang L, Li L, Ji CC, Zheng MH, Han H. 2014. Hif-1α and Hif-2α differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells. Cancer Lett 349:67–76. https://doi.org/10.1016/j.canlet.2014.03.035.
  • Arsenault PR, Pei F, Lee R, Kerestes H, Percy MJ, Keith B, Simon MC, Lappin TR, Khurana TS, Lee FS. 2013. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism. J Biol Chem 288:33571–33584. https://doi.org/10.1074/jbc.M113.482364.
  • Johnson DW, Pollock CA, MacDougall I. 2007. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology 12:321–330. https://doi.org/10.1111/j.1440-1797.2007.00810.x.
  • Flygare J, Estrada VR, Shin C, Gupta S, Lodish HF. 2011. HIF1α synergizes with glucocorticoids to promote BFU-E progenitor self-renewal. Blood 117:3435–3444. https://doi.org/10.1182/blood-2010-07-295550.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.